Switch to:
More From Other Websites
Impax to Report Fourth Quarter 2014 Results on February 24, 2015 Jan 29 2015
Teva Gains FDA Nod for Generic of AstraZeneca's Nexium - Analyst Blog Jan 28 2015
Actavis to Buy Auden Mckenzie, Boost Generic Portfolio - Analyst Blog Jan 27 2015
Supernus Files Oxtellar XR Patent Infringement Lawsuit Again - Analyst Blog Jan 26 2015
Impax Receives FDA Approval for a Generic Version of Lamictal® Orally Disintegrating Tablets (ODT) Jan 26 2015
Impax Receives FDA Approval for a Generic Version of Lamictal® Orally Disintegrating Tablets (ODT) Jan 26 2015
Bayer Announces Updates to European Label of Xarelto - Analyst Blog Jan 21 2015
Bristol-Myers Makes Leadership Changes, Names New CEO - Analyst Blog Jan 21 2015
Hospira's Plum 36O Infusion System Gets FDA Clearance - Analyst Blog Jan 21 2015
Teva Up on Positive Copaxone Supreme Court Ruling - Analyst Blog Jan 21 2015
Agile Therapeutics (AGRX) Soars: Stock Up 15.9% in Session - Tale of the Tape Jan 21 2015
Actavis/Gedeon Richter Present Schizophrenia Drug Data - Analyst Blog Jan 20 2015
Corium International (CORI) Jumps: Stock Rises 13.9% - Tale of the Tape Jan 16 2015
Can the Rally in Impax Laboratories (IPXL) Shares Continue? - Tale of the Tape Jan 15 2015
IMPAX LABORATORIES INC Files SEC form 8-K, Other Events Jan 14 2015
Impax Laboratories Expects More M&A After Latest Deal Closes Jan 14 2015
IMPAX LABORATORIES INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Jan 13 2015
UPDATE 1-Impax's Parkinson's drug gets FDA approval Jan 08 2015
Impax's Parkinson's drug gets FDA approval Jan 08 2015
BUZZ-U.S. STOCKS ON THE MOVE-Aeropostale, Ford, Bind Therapeutics Jan 08 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK